Friday, December 12, 2025
11.7 C
London

Tag: ImmunoOncology

Imugene: Receives $4.8M tax rebate on cancer research

Clinical-stage immuno-oncology company Imugene (IMU) has received a hefty tax rebate for its research and development (R&D) spending ...

Imugene: Receives FDA approval for PD1-Vaxx trial

Imugene (IMU) has received approval from the U.S. Food and Drug Administration (FDA) to begin a clinical trial...